2010 Foreign Corrupt Practices Act Mid-Year Webcast Series: FCPA and the Pharmaceutical Industry

Following the highly successful first and second webcasts in this four-part series, we invite you to join Morgan Lewis for part four on September 14.

The final program of the series, "FCPA and the Pharmaceutical Industry," will focus on implications of the FCPA in the pharmaceutical industry.

Topics will include:

• Overview of the FCPA and the 2010 U.K. Bribery Act
• Enforcement trends and the pharmaceutical industry
• Compliance programs and third-party due diligence
• Responding to an allegation